We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Active After Cancer Trial (AACT) (AACT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00548236
Recruitment Status : Active, not recruiting
First Posted : October 23, 2007
Last Update Posted : June 2, 2016
Cancer and Leukemia Group B
Information provided by (Responsible Party):
Jennifer A. Ligibel, MD, Dana-Farber Cancer Institute

Brief Summary:
This study is being done to determine whether a telephone-based counseling intervention can help survivors of breast and colorectal cancer increase their weekly physical activity. Observational evidence suggests that physical activity after breast and colorectal cancer diagnosis decreases recurrence rates. Unfortunately, many people become less active during cancer therapy, and a substantial proportion never return to pre-diagnosis levels of physical activity. This study looks to see if people who have recently finished chemotherapy for breast, colon or rectal cancer can be motivated to increase their exercise by talking to an exercise specialist over the phone. The study also looks at changes in mood, fatigue, fitness, fat distribution and weight.

Condition or disease Intervention/treatment
Breast Cancer Colorectal Cancer Behavioral: Telephone-Based exercise intervention

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Pilot Study of a Multicenter, Telephone-Based Exercise Intervention for Patients With Early-Stage Breast and Colorectal Cancer: The Active After Cancer Trial (AACT)
Study Start Date : October 2007
Primary Completion Date : March 2010
Estimated Study Completion Date : July 2017

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1
Immediate participation in a 16-week exercise program
Behavioral: Telephone-Based exercise intervention
Exercise counselling offered via telephone calls
No Intervention: 2
Control population; will receive exercise plan after 16-week control period

Primary Outcome Measures :
  1. To evaluate the ability of a multi-center, telephone-based physical activity intervention to increase weekly physical activity levels in sedentary patients treated with adjuvant chemotherapy for Stage I-III breast or colorectal cancer. [ Time Frame: months ]

Secondary Outcome Measures :
  1. To evaluate the impact of a physical activity intervention upon fitness, exercise self-efficacy, anthropometric measures, and quality of life in a group of patients with stage I-III breast or colorectal cancer. [ Time Frame: months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Histologically confirmed stage I-III breast or colorectal cancer
  • 18 years of age or older
  • Completed adjuvant treatment(for current malignancy)
  • Completion of all adjuvant chemotherapy and radiation (with the exception of adjuvant herceptin and/or tamoxifen/aromatase inhibitor therapy for breast cancer patients) between 2 and 36 months prior to enrollment
  • Ability to speak and read English
  • Willingness to be randomized
  • Medical clearance from an oncologist or primary care physician stating the participant is able to participate in an unsupervised, moderate-intensity physical activity program
  • No major surgery within 2 months of study enrollment or planned during study period

Exclusion Criteria:

  • Metastatic cancer
  • Uncontrolled intercurrent illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness that would limit compliance with study requirements
  • Plans to have hip or knee replacement within a year
  • Participation in more than 60 minutes a week of moderate-intensity recreational activity as assessed by the International Physical Activity Questionnaire Short Form
  • BMI >47

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00548236

United States, California
University of California at San Diego
LA Jolla, California, United States, 92093
University of California San Francisco
San Francisco, California, United States, 94143
United States, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115
United States, New Hampshire
New Hampshire Oncology Hematology
Concord, New Hampshire, United States, 03106
Lakes Regional Healthcare Hematology Oncology
Hooksett, New Hampshire, United States, 03106
United States, New York
Rosewell Park Cancer Institute
Buffalo, New York, United States, 14263
Hematology Oncology Associates of Central New York
East Syracuse, New York, United States, 13057
United States, Ohio
Ohio State University
Columbus, Ohio, United States, 43210
United States, Vermont
Vermont Cancer Center
Burlington, Vermont, United States, 05401
Sponsors and Collaborators
Dana-Farber Cancer Institute
Cancer and Leukemia Group B
Principal Investigator: Jennifer Ligibel, MD Dana-Farber Cancer Institute

Responsible Party: Jennifer A. Ligibel, MD, Assistant Professor, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier: NCT00548236     History of Changes
Other Study ID Numbers: 07-266
First Posted: October 23, 2007    Key Record Dates
Last Update Posted: June 2, 2016
Last Verified: June 2016

Keywords provided by Jennifer A. Ligibel, MD, Dana-Farber Cancer Institute:
exercise intervention

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases